clanger

What's Happening at Pfizer Right Now?

The funny thing is that your colleague Mr. Huckman was told of this months earlier by myself and has chosen not to investigate or report what PFE's strategy is with regards to personalized medicine. Instead he chose to concentrate on the negatives and well known, well analyzed obvious facts.

It is noteworthy that Roche is now in talks with Rosetta Genomics (ROSG) after having already struck a deal with Alnylam.

Makes PFE look like a sloth.